A 2-Week Ketogenic Diet in Combination With Letrozole to Modulate PI3K Signaling in ER+ Breast Cancer

NCT03962647 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Estrogen Receptor-positive Breast Cancer

Interventions

DIETARY_SUPPLEMENT: 2-Week Ketogenic Diet
DRUG: Letrozole

Sponsor

Vanderbilt-Ingram Cancer Center